Parkin coordinates mitochondrial lipid remodeling to execute mitophagy.

Fiche publication

Date publication

octobre 2022

Journal

EMBO reports

Auteurs

Membres identifiés du Cancéropôle Est :
Dr VITALE Nicolas

Tous les auteurs :
Lin CC, Yan J, Kapur MD, Norris KL, Hsieh CW, Huang,Vitale N, Lim KL, Guan Z, Wang XF, Chi JT, Yang WY, Yao TP

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36256516

Résumé

Autophagy has emerged as the prime machinery for implementing organelle quality control. In the context of mitophagy, the ubiquitin E3 ligase Parkin tags impaired mitochondria with ubiquitin to activate autophagic degradation. Although ubiquitination is essential for mitophagy, it is unclear how ubiquitinated mitochondria activate autophagosome assembly locally to ensure efficient destruction. Here, we report that Parkin activates lipid remodeling on mitochondria targeted for autophagic destruction. Mitochondrial Parkin induces the production of phosphatidic acid (PA) and its subsequent conversion to diacylglycerol (DAG) by recruiting phospholipase D2 and activating the PA phosphatase, Lipin-1. The production of DAG requires mitochondrial ubiquitination and ubiquitin-binding autophagy receptors, NDP52 and optineurin (OPTN). Autophagic receptors, via Golgi-derived vesicles, deliver an autophagic activator, EndoB1, to ubiquitinated mitochondria. Inhibition of Lipin-1, NDP52/OPTN, or EndoB1 results in a failure to produce mitochondrial DAG, autophagosomes, and mitochondrial clearance, while exogenous cell-permeable DAG can induce autophagosome production. Thus, mitochondrial DAG production acts downstream of Parkin to enable the local assembly of autophagosomes for the efficient disposal of ubiquitinated mitochondria.